Which classification of drugs is contraindicated for the client with hypertrophic cardiomyopathy (HCM)?

NORCET 5 mains

Medical & Surgical Nursing

Medium

Appeared in: NORCET 5 mains

Explanation

In hypertrophic cardiomyopathy (HCM), especially the obstructive form, the heart muscle is thickened, which can block blood flow out of the left ventricle.
Positive inotropic agents (like digoxin, dobutamine) increase the force of the heart's contraction.
This stronger contraction intensifies the obstruction by making the thickened muscle bulge more into the outflow tract.
Worsening the obstruction reduces cardiac output and increases the risk of severe symptoms and sudden cardiac death, making these drugs contraindicated.

Option B: Vasodilators are not the primary contraindication. While they must be used with extreme caution in obstructive HCM because they can reduce blood pressure and worsen the outflow gradient, they are not absolutely contraindicated in all cases and may be used by specialists.
Option C: Diuretics are not absolutely contraindicated. They are used cautiously in HCM to manage symptoms of fluid overload and congestion.
Option D: Antidysrhythmics are often indicated, not contraindicated, in clients with HCM. Arrhythmias, particularly atrial fibrillation, are common and poorly tolerated in HCM, and these drugs are used to prevent or control them.

Visual 1: Diagram: Comparison of a normal heart and a heart with hypertrophic obstructive cardiomyopathy (HOCM), clearly illustrating the thickened septum and narrowed left ventricular outflow tract (LVOT).
Visual 2: Animation: Depiction of blood flow through the LVOT in a normal heart versus an HOCM heart, showing how a forceful contraction (positive inotropic effect) worsens the obstruction.

Clinical Relevance

Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Pharmacological contraindications in hypertrophic cardiomyopathy (HCM) as background academic context rather than a clinical decision trigger.
A nurse must be vigilant about medication safety for HCM patients. Administering a positive inotrope can trigger a life-threatening event.
Key nursing assessments include monitoring for signs of worsening obstruction, such as dizziness, syncope, dyspnea on exertion, and chest pain, especially after medication administration.
Patient education is critical. The nurse should teach the patient and family about which medications to avoid and the importance of informing all healthcare providers about their HCM diagnosis.

How to Approach the Question

First, identify the core disease process: Hypertrophic Cardiomyopathy (HCM). Recall that its defining feature is a thickened heart muscle.
Understand the key complication of HCM: the thickened muscle can obstruct blood flow out of the heart (Left Ventricular Outflow Tract obstruction).
Analyze the question's focus: it asks for a 'contraindicated' drug class, meaning a drug that would be harmful.
Evaluate each option based on its effect on the heart's mechanics in the context of HCM.
Consider Positive Inotropes: They increase contraction force. Would a stronger squeeze help or hurt an obstructed outflow? It would hurt by worsening the obstruction.
Consider Vasodilators and Diuretics: They affect blood volume and pressure. Their effect is indirect and requires caution, but they aren't the primary 'harmful' mechanism.

Concept Tested & Keywords

Concept Tested: Pharmacological contraindications in hypertrophic cardiomyopathy (HCM)
Stem keywords: hypertrophic cardiomyopathy, HCM, contraindicated, drugs
Lead-in keywords: Which
Negative lead-in flag: false

Qe_ymK6b-Mg5Sh0t4kAMk1